A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D

• Status: Completed
• Trial end date: 2013-12-01

Summary

The purpose of this study is to compare the efficacy and safety of intravenous iron isomaltoside 1000 with intravenous iron sucrose in patients suffering from Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D).

• Phase: Phase 3

Details

• Lead Sponsor: Pharmacosmos A/S
• Treatments: Ferric Compounds; Ferric Oxide, Saccharated; Iron